Partnering Up for Cardiac Hypertrophy

Circulation Research - United States
doi 10.1161/01.res.0000221823.31424.47
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

cGMP and Cardiac Hypertrophy

BMC pharmacology & toxicology
MedicinePharmacology
2015English

Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy: A Novel Mechanism for Progressive Cardiac Hypertrophy

Hypertension
Internal Medicine
2010English

Partnering for Perfection

English

Non-Coding RNAs in Cardiac Hypertrophy

Journal of Physiology
PhysiologySports Science
2017English

Mechanotransduction in Cardiac Hypertrophy and Failure

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2015English

Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Japanese Heart Journal
1974English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2020English

The Function of miRNA in Cardiac Hypertrophy

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2012English

Tripartite Motif 32 Prevents Pathological Cardiac Hypertrophy

Clinical Science
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy